miRagen Therapeutics, Inc.
M&A
Category | Healthcare / Biotech |
---|---|
Business Line | Development of nuclid acid therapeutics targeting microRNAs |
URL | http://miragentherapeutics.com/ |
President | William S. Marshall, Ph.D. |
Establishment | July 2007 |
Initial Investment | October 2015 |